Clinical Trial Update: Efficacy and Safety of a Third-Course of Neoadjuvant Immunochemotherapy Combined With SBRT in Locally Advanced Head and Neck Squamous Cell Carcinoma Patients With Stable Disease After Two Treatment Courses: A Single-Arm Exploratory Study [NA]

View source ↗

Summary

Clinical trial update on the efficacy and safety of a third course of neoadjuvant immunochemotherapy combined with SBRT for locally advanced head and neck squam…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: SBRT, Neoadjuvant Immunochemotherapy | NA | Status: NOT_YET_RECRUITING